Understanding long-acting injectable antipsychotics for better treatment adherence

Research output: Contribution to journalArticlepeer-review

Abstract

LAI antipsychotics have been available to providers for more than 40 years yet they appears to be underutilized. LAI second-generation antipsychotics have been well-studied in clinical situations and in regulatory trials their adverse effects are well understood. LAI antipsychotics offer providers a viable option to help with medication adherence and reduce any potential gaps in treatment.

Original languageEnglish
Pages (from-to)31-34
Number of pages4
JournalPsychiatric Times
Volume37
Issue number3
StatePublished - Mar 2020

Fingerprint Dive into the research topics of 'Understanding long-acting injectable antipsychotics for better treatment adherence'. Together they form a unique fingerprint.

Cite this